menu
    • menu

    Company profile for IM Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IMT is the first company to target the root cause of autoimmunity with therapeutic design directed at HLA variants known to confer high disease risk. The Company platform builds drug molecules for specific blockade of an HLA protein in a given autoimmune disease as a novel paradigm in drug development. Our drug development of oral therapies employs a unique approach to balance the affinity to HLA binding site(s) to achieve bl...
    IMT is the first company to target the root cause of autoimmunity with therapeutic design directed at HLA variants known to confer high disease risk. The Company platform builds drug molecules for specific blockade of an HLA protein in a given autoimmune disease as a novel paradigm in drug development. Our drug development of oral therapies employs a unique approach to balance the affinity to HLA binding site(s) to achieve blockade versus protecting inherent immunity against pathogens conferred by the HLA proteins.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IM TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    299 Washington St. Suite A Woburn, MA 01801
    Telephone
    Telephone
    +1 303.544.2104
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.imtherapeutics.com/company-overview
    Linkedin
    Linkedin
    https://www.linkedin.com/company/im-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IM Therapeutics Reports Positive Results of Phase 1b Trial of Lead Drug IMT-002
    IM Therapeutics Reports Positive Results of Phase 1b Trial of Lead Drug IMT-002

    21 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210721005071/en

    BUSINESSWIRE
    21 Jul 2021
    Share Share
    IM Therapeutics' lead diabetes candidate posts positive results
    IM Therapeutics' lead diabetes candidate posts positive results

    21 Jul 2021

    // Kyle LaHucik FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/im-therapeutics-posts-positive-results-for-phase-1b-study-type-1-diabetes

    Kyle LaHucik FIERCEBIOTECH
    21 Jul 2021
    Share Share
    IM Co-Founder Peter Gottlieb, M.D, to Present Advances in Genetically
    IM Co-Founder Peter Gottlieb, M.D, to Present Advances in Genetically

    26 Jun 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210624005253/en

    BUSINESSWIRE
    26 Jun 2021
    Share Share
    IM Therapeutics Expands Management Team with David Alleva
    IM Therapeutics Expands Management Team with David Alleva

    06 Apr 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210406005260/en/IM-Therapeutics-Expands-Management-Team-with-David-Alleva-Ph.D.-as-VP-Immunology

    BUSINESSWIRE
    06 Apr 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search